(secondQuint)Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration.

 This is a Phase 1, open-label, parallel group study in healthy female subjects.

 The study is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of a single dose of Fulvestrant for Injectable Suspension vs.

 the reference drug, Faslodex, administered in the gluteal muscle.

.

 Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration@highlight

Clinical study designed to assess the plasma pharmacokinetic profile and tolerability of Fulvestrant for Injectable Suspension after a single IM dose of Fulvestrant for Injectable Suspension compared to the reference product, Faslodex in healthy female subjects.

